|
HS Code |
386002 |
| Generic Name | Clomiphene Citrate |
| Brand Names | Clomid, Serophene |
| Drug Class | Selective Estrogen Receptor Modulator (SERM) |
| Dosage Form | Oral tablet |
| Primary Use | Infertility treatment |
| Mechanism Of Action | Stimulates ovulation by blocking estrogen receptors in the hypothalamus |
| Usual Dosage | 50 mg once daily for 5 days |
| Prescription Status | Prescription only |
| Common Side Effects | Hot flashes, abdominal pain, bloating, nausea, breast tenderness |
| Pregnancy Category | Category X |
As an accredited Clomiphene Citrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Clomiphene Citrate packaging displays 50 mg tablets, 30-count per box, with dosage instructions, batch number, and manufacturer details printed clearly. |
| Shipping | Clomiphene Citrate is shipped in secure, tightly sealed containers, protected from light and moisture. Packaging ensures safety and regulatory compliance, with clear labeling for identification. Transport typically requires ambient temperature, avoiding extreme heat or freezing conditions. All shipments comply with applicable pharmaceutical and chemical handling and import/export regulations. |
| Storage | Clomiphene Citrate should be stored at room temperature, typically between 20°C to 25°C (68°F to 77°F), in a tightly closed container. Protect it from light, moisture, and excessive heat. Keep the chemical in a dry, well-ventilated area, away from incompatible substances and out of reach of children or unauthorized personnel. Follow all regulatory guidelines for storage. |
|
Purity 99%: Clomiphene Citrate with purity 99% is used in assisted reproductive technology clinics, where it promotes consistent ovulation induction for infertile women. Melting Point 116–118°C: Clomiphene Citrate with a melting point of 116–118°C is used in pharmaceutical formulations manufacturing, where it ensures thermal stability during tablet production. Particle Size <10 microns: Clomiphene Citrate with particle size less than 10 microns is used in oral dosage forms, where it enhances bioavailability and rapid absorption. Solubility in Ethanol: Clomiphene Citrate with high solubility in ethanol is used in solution preparation for laboratory analysis, where it allows precise dosing and uniform sample preparation. Stability at 25°C: Clomiphene Citrate with confirmed stability at 25°C is used in long-term storage conditions, where it maintains its potency and effectiveness over extended periods. Assay ≥98%: Clomiphene Citrate with assay greater than or equal to 98% is used in clinical research studies, where it provides reproducible and reliable treatment outcomes. Moisture Content ≤0.5%: Clomiphene Citrate with moisture content less than or equal to 0.5% is used in pharmaceutical compounding, where it ensures product integrity and prevents degradation. Residual Solvent <0.1%: Clomiphene Citrate with residual solvent below 0.1% is used in quality-controlled drug production, where it ensures patient safety and regulatory compliance. |
Competitive Clomiphene Citrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Clomiphene Citrate stands as one of the most recognized names in fertility medicine. Patients and healthcare professionals turn to it as a first line therapy for certain types of infertility in women, particularly those not ovulating regularly. The path through fertility challenges can feel overwhelming. Clomiphene plays a role in guiding this journey, offering a tangible step to those longing to start a family.
Typically found in tablet form, patients know the drug by its two common strengths: 25 mg and 50 mg, with most clinical protocols favoring the 50 mg tablet. The active ingredient, Clomiphene Citrate, helps encourage ovulation by influencing the hormonal balance, an essential action in women with polycystic ovary syndrome (PCOS) and similar conditions. People often refer to it by brand names, but the generics have the same effect when taken as prescribed and sourced from regulated suppliers.
The underlying challenge for many women facing fertility struggles is irregular or absent ovulation. Clomiphene addresses this by acting at the brain level, specifically on the hypothalamus. The medication convinces the brain that the body’s levels of estrogen are lower than they actually are. This leads the pituitary gland to release more follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The result? Ovaries receive the necessary signals to mature and release an egg.
Drawing from my time supporting friends through infertility treatment, the appeal of a relatively simple, oral medication is hard to overstate. Some infertility drugs require injections, demand intense monitoring, and carry higher risks for hormonal side effects. Clomiphene, by contrast, comes as a pill taken once a day for five days, often starting between day three and day five of a woman’s menstrual cycle. This straightforward schedule means less disruption, both in daily life and emotionally. That matters when navigating the medical and psychological maze of fertility care.
Many doctors view Clomiphene as a practical low-intervention starting point in fertility care. Its cost remains manageable and insurance often covers its use. For many families, these factors open doors that might otherwise remain closed. According to American Society for Reproductive Medicine, about 70-80% of women with ovulatory dysfunction will successfully ovulate on Clomiphene. Of those who ovulate, about a quarter become pregnant within a few cycles.
Looking beyond the statistics, stories from real people give the clearest sense of its impact. I have listened to patients and their partners describe the emotional boost that comes with having a plan. Taking Clomiphene is more than just swallowing tablets; for some, it marks the first hope they have felt in months or years. At the same time, it's worth remembering that fertility treatment is never a guarantee. There are heartaches along the way, especially when expectations are high. Still, starting with something accessible and trusted can be reassuring for many.
Other fertility medications exist, ranging from injectable gonadotropins to aromatase inhibitors like letrozole. Each option brings its own advantages and drawbacks. Injectables can be powerful but carry a steeper risk of ovarian hyperstimulation and multiple pregnancies. They often demand careful dose titration, frequent blood tests, and ultrasounds.
Letrozole, originally developed to treat breast cancer, has earned a place in the toolkit for ovulation induction. Some studies suggest letrozole may work better for women with PCOS, but Clomiphene remains widely trusted thanks to decades of experience and extensive safety data. For women without PCOS who simply do not ovulate, Clomiphene often spurs ovulation just as effectively as any other drug, while being easier to access and typically less expensive.
From my perspective, the broad utility and oral dosing of Clomiphene provide key advantages. Women can use it in their own homes without needing injections and complex medical schedules. The oral route makes sticking to the treatment plan easier for most. And, in settings where infertility care infrastructure lags—rural areas, lower-income clinics—the simplicity and affordability of Clomiphene give it clear practical appeal.
Like all medications, Clomiphene comes with risks. Its stimulatory effect on the ovaries sometimes leads to hot flashes, mood swings, headaches, or abdominal discomfort. On rare occasions, it increases the risk of ovarian hyperstimulation, most commonly with higher doses or repeated rounds. Visual disturbances—little flashes of light or blurring—make for an unusual but well-documented concern. Doctors watch for these symptoms and recommend stopping the drug if they appear.
Clomiphene also nudges the likelihood of twins or triplets above the background rate. This isn’t always unwelcome news, but a multiple pregnancy brings more health risks for both mother and babies. Still, rates of higher-order multiples (triplets or more) remain lower with Clomiphene than with injectable fertility medications. Careful monitoring and conservative dosing help avoid the real trouble spots.
Stories from people I know who have gone through ovulation induction often include both relief and occasional frustration about the symptoms. Many women report temporary hot flashes or moodiness, but most tolerate the medication well. Having a trusted healthcare provider who listens to concerns and adjusts plans as needed makes a real difference.
Clomiphene works best for women with documented ovulation problems, excluding those with blocked fallopian tubes or severe male infertility. Doctors usually run a panel of tests before starting treatment. The medication does not address problems caused by structural barriers to pregnancy—so it won’t help if both tubes are blocked or if the uterus has certain anomalies.
It’s also not suited for women with certain hormone-dependent tumors, uncontrolled thyroid or adrenal problems, or liver disease. The importance of a proper diagnosis before starting treatment cannot be overstated. Doctors also limit the number of Clomiphene cycles—commonly no more than six—since most pregnancies occur within the first three attempts, and risks may rise with prolonged use.
People facing fertility treatment face complicated choices. Clomiphene stands out as the least invasive and most affordable entry point. Injectable medications, though effective, often seem daunting both for cost and complexity. Even newer oral drugs like letrozole have less history behind them in the context of ovulation induction. For physicians, Clomiphene represents a tool with well-charted territory.
Patients going through infertility evaluation often appreciate having a stepwise approach. Starting with oral medication builds experience, understanding, and trust on both sides. If Clomiphene works, great. If not, teams can move to more advanced interventions with greater confidence that simpler solutions have been tried.
Major guidelines agree on Clomiphene’s position as a primary therapy for unexplained infertility and anovulation. Research spanning several decades has clarified not just the benefits but also the tradeoffs involved. As more people seek fertility help at older ages, some studies evaluate the best protocols for these patients and who stands to gain most.
While new medications and treatment protocols appear each year, Clomiphene’s value persists. Clinicians appreciate having a medication with clear dosing and predictable side effects, making it a practical choice for both private clinics and large public hospitals. For patients, the volume of real-world experience and peer support resources available for Clomiphene users can make a daunting journey feel less lonely.
No single fertility drug fits every patient. Clomiphene’s advantages—oral dosing, long history, and low cost—make it appealing to many women and couples, especially at the start of treatment. Reproductive endocrinologists and primary care doctors alike prescribe it with confidence, but always within a broader care pathway.
Pharmacies carry the brand and generic versions. Regulatory agencies in most countries have approved it for years, and supply chains support consistent access. Doctors and patients alike appreciate medications that do not introduce unexpected hurdles or price spikes.
In my experience, patients value knowing what to expect. Open conversations about both benefits and risks leave room for informed choices. For example, couples often want to know how soon they’ll need additional testing or procedures if Clomiphene doesn’t bring success after a few tries. Transparent communication supports not only individual outcomes but also emotional well-being during a stressful period.
The story of fertility medicine includes barriers tied to cost, geography, and insurance coverage. Clomiphene’s cost is relatively low, which allows more couples and individuals a chance to try treatment before moving to expensive interventions. In places where fertility clinics and specialists may be hundreds of miles away, access to prescription oral medications keeps hope alive for families with limited resources.
Still, some issues remain. Not every doctor feels at ease handling infertility questions, which leads to varying levels of treatment quality or missed opportunities. Efforts to expand training, support navigation services, and destigmatize conversations about infertility carry just as much weight as introducing new therapies. Even the best medication only goes as far as the system in which it’s delivered.
There’s active research on tailoring Clomiphene therapy for specific groups. Some efforts focus on identifying which patients are less likely to respond, reducing wasted time and frustration. Early treatment with lifestyle modifications for overweight or obese women—along with careful partner evaluation—helps reduce delays and targets therapy more effectively.
Public health initiatives that improve access to comprehensive reproductive care put medications like Clomiphene in context. Streamlined referral pathways and patient education campaigns can speed up time to diagnosis and treatment, helping families reach their goals sooner. Sharing information in clear, open language lets people weigh options for themselves and ask informed questions.
People struggling with infertility deserve practical, affordable, and reliable options. Clomiphene fulfills these roles while supporting shared decision-making between patients and clinicians. Sitting in waiting rooms or reading fertility forums, one hears the relief from people for whom Clomiphene worked—and the gratitude for a path that started with an accessible medication. The journey often includes setbacks, but seeing a first positive test after years of trying can feel like a life-changing moment.
For older patients or those with additional complications, Clomiphene may not always represent the endpoint, but as a first step it brings real benefits. Fertility care continues to evolve, but a solution grounded in decades of experience continues to hold a firm place. New pathways and drugs will keep arriving, but the lessons from Clomiphene—simple delivery, solid data, affordability—set an important standard for the field.
The meaning of Clomiphene Citrate goes beyond test tubes and hormones. It represents hope for people across backgrounds and life situations. Open communication, good science, and strong support networks all come together to make fertility care more accessible. In doctor’s offices, community clinics, and support groups, Clomiphene remains a testament to the progress made and the work ahead to make family-building possible for all who pursue it.
From a writer’s perspective influenced by real experience, clarity and practical advice matter most. Clomiphene Citrate continues to provide a balance of these values—offering not just a medication, but a cornerstone of hope for families across the world.